Illumina Investors Claim Goldman Bias In Suit Over Roche Bid
A group of Illumina Inc. shareholders launched a putative class action Tuesday accusing the gene sequencing company and its board of directors of deciding to reject a takeover bid by drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article